FDA Investigator Lourdes Valentin Aponte
Lourdes Valentin Aponte has conducted inspections on 18 sites in 7 countries as of 02 Jun 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
18
Last Inspection Date:
02 Jun 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Spain,
France,
Austria,
Portugal,
Mexico,
Argentina,
United Kingdom of Great Britain and Northern Ireland
FDA Investigators that have inspected at least one site in common with Lourdes Valentin Aponte:
Adetutu M Gidado,
Ana P Pineda Zavaleta,
Anthony A Charity,
Azza Talaat,
Brunilda Torres,
Charles R Cote, RIC,
Cynthia Jim, CSO,
Demitria J Xiradakis,
Eric M Mueller, PharmD,
Erika V Butler,
Gwyn G Dickinson,
Heriberto Negron Rivera,
Javier E Santos,
Jeffrey A Sommers,
Joel D Hustedt,
Joel D Martinez,
José E Meléndez,
Juan Rjimenez Garcia,
Kent C Faul,
Lisa Shin,
Lloyd D Payne,
Lucas B Leake,
Luis A Carrion,
Michael P Sheehan,
Mra Digiuliod,
Mra M Barbosar,
Nancy A Bellamy,
Rafael Nevarez Nieves,
Raquel Gonzalez Rivera,
Rebecca E Dombrowski,
Robert C Coleman,
Steven A Gonzales,
Susan T Hadman,
Susanna E Ford,
Tamil Arasu, PhD,
Tiffani D Wilson,
Vlada Matusovsky
Lourdes Valentin Aponte's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2000 | EIR | Industrias Farmaceuticas Almirall SA - EIR, 2001-03-26 |
May, 2000 | EIR | Ranke Química, SA - EIR, 2000-11-02 |
January, 2001 | EIR | Dr. H. Jakubek - EIR, 2001-02-20 |
January, 2001 | EIR | Dr. M. Fouche - EIR, 2001-02-20 |
January, 2001 | FDA 483 Response | Dr. H. Jakubek - Form 483R, 2001-02-06 |
May, 2000 | FDA 483 Response | Industrias Farmaceuticas Almirall SA - Form 483R, 2001-01-29 |
January, 2001 | FDA 483 Response | Dr. M. Fouche - Form 483R, 2001-01-26 |
May, 2000 | FDA 483 Response | Ranke Química, SA - Form 483R, 2000-11-20 |
May, 2000 | FDA 483 | Sandoz Industrial Products SA - Form 483, 2000-05-17 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more